ETNK2 and gastric cancer: We performed an in-depth analysis of GC cell lines with ETNK2 knockout (KO) and/or overexpression in vitro and in vivo and additionally analysed ETNK2 expression in GC tissue specimens and evaluated its potential utility as a biomarker of hepatic metastasis in GC patients.